Pol Arch Intern Med. 2024 May 14:16749. doi: 10.20452/pamw.16749. Online ahead of print.
NO ABSTRACT
PMID:38747414 | DOI:10.20452/pamw.16749
Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, dexamethasone or lenalidomide alone
by | May 15, 2024 | Publications | 0 comments